La Nueva Era del Tratamiento de la Obesidad | Highlights ADA 2026

The New Era of Obesity Treatment: From Ultra-Long-Acting GLP-1 Agonists to the Neurobiology of Hunger | Highlights ADA 2026 Dr. Javier Solís presents the lecture "The New Era of Obesity Treatment: From Ultra-Long-Acting GLP-1 Agonists to the Neurobiology of Hunger," delivered during the Highlights ADA 2026 scientific update session, organized by the Ecuadorian Society of Endocrinology, Metabolism, Diabetes, and Nutrition – Pichincha Chapter. This lecture analyzes the latest advances in the pharmacological treatment of obesity, including the development of ultra-long-acting GLP-1 receptor agonists, new therapies under investigation, and discoveries regarding the neurobiology of hunger and appetite regulation. This presentation also reviews how these advances are transforming the clinical approach to obesity as a chronic disease, based on the scientific evidence presented at the ADA Scientific Sessions 2026. This presentation is part of an academic conference in which Ecuadorian specialists shared and analyzed the main developments presented during the American Diabetes Association (ADA) Scientific Sessions 2026, strengthening continuing medical education and evidence-based clinical practice. Organized by the Ecuadorian Society of Endocrinology, Metabolism, Diabetes and Nutrition – Pichincha Chapter. 🔔 Subscribe to our channel to access more conferences, scientific sessions, and updated content on endocrinology, diabetes, metabolism, and nutrition. Follow us on our social media to learn about our upcoming academic activities and scientific events. #ADA2026 #HighlightsADA2026 #Obesity #GLP1 #NeurobiologyOfHunger #Endocrinology #Diabetes #Metabolism #ContinuingMedicalEducation #EvidenceBasedMedicine #EcuadorianSocietyOfEndocrinology